Views & Analysis

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow

From trial design for patients to trial design with patients: a key topic at DIA ’22

https://pharmaphorum.com/patients/from-trial-design-for-patients-to-trial-design-with-patients-a-key-topic-at-dia-22/

R&D/ Views & Analysis/ Views and analysis

Preventing the next pandemic: Learning the lessons

Ben Hargreaves covid, pandemic, pharma, WHO 0 Comment

In the first of a three part series, Ben Hargreaves looks at what the odds are of another

Preventing the next pandemic: Learning the lessons

https://pharmaphorum.com/r-d/preventing-the-next-pandemic-learning-the-lessons/

R&D/ Views & Analysis/ Views and analysis

New countries stockpile antiviral TPOXX as monkeypox outbreak continues

Jonah Comstock monkeypox, orthopox, Philip Gomez, SIGA technologies, vaccines 0 Comment

pharmaphorum editor in chief Jonah Comstock talks to Philip Gomez, CEO of Siga Technologies, about how his company’s

New countries stockpile antiviral TPOXX as monkeypox outbreak continues

https://pharmaphorum.com/r-d/new-countries-stockpile-antiviral-tpoxx-as-monkeypox-outbreak-continues/

Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Evaluate’s Orphan Drug Report shows rapid acceleration in the space

Jessica Hagen Andreas Hadjivasiliou, Evaluate, Orphan Drug Report, orphan drugs, Paul Verdin 0 Comment

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the

Evaluate’s Orphan Drug Report shows rapid acceleration in the space

https://pharmaphorum.com/market-access-2/evaluates-orphan-drug-report-2022/

Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials

Ben Hargreaves biologic medicines, China, fda, Lilly 0 Comment

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates

FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials

https://pharmaphorum.com/market-access-2/fdas-treatment-of-china-developed-drugs-spurs-demands/

R&D/ Views & Analysis/ Views and analysis

Combating antimicrobial resistance with a viable alternative to traditional antibiotics

mike.hammerton@pharmaphorum.com AMR, anti microbial resistance, antibacterial resistance, Micreos Pharmaceuticals, MRSA 0 Comment

Antimicrobial resistance (AMR) is an issue of global concern, killing roughly 1.2 million1 people per year and projected

Combating antimicrobial resistance with a viable alternative to traditional antibiotics

https://pharmaphorum.com/r-d/views-analysis-r-d/combating-antimicrobial-resistance-viable-alternative-traditional-antibiotics/

R&D/ Views & Analysis/ Views and analysis

Can technology help diversify clinical trials?

mike.hammerton@pharmaphorum.com clinical trials, decentralised clinical trials, diversity, diversity and inclusion, KPMG 0 Comment

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create

Can technology help diversify clinical trials?

https://pharmaphorum.com/r-d/can-technology-help-diversify-clinical-trials/

R&D/ Views & Analysis/ Views and analysis

Why are clinical trials struggling with diversity?

mike.hammerton@pharmaphorum.com clinical trial diversity, clinical trials, COVID-19, diversity, diversity and inclusion, randomised control trials 0 Comment

In the diverse world we live in, the products we produce, the services we create and the places

Why are clinical trials struggling with diversity?

https://pharmaphorum.com/r-d/why-are-clinical-trials-struggling-with-diversity/

Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Conducting successful commercial research in a primary care setting

Eloise McLennan clinical trials, GSK, Healum, NIHR, primary care 0 Comment

The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research.

Conducting successful commercial research in a primary care setting

https://pharmaphorum.com/patients/conducting-successful-commercial-research-in-a-primary-care-setting/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views & Analysis

Login